Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmBisome in Candidemia and Invasive Candidiasis
NCT00670657Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal amphotericin b in candidemia, invasive candidiasis, sponsored by Gilead Sciences. Started May 2007; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NCT00670657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670657.